ArrePath Company
ArrePath is an anti-infective drug discovery company addressing the global health challenge of drug resistant infections.
Investors
Connections from
Funding Status:
Seed
Industry:
Early Drug Development
Investors Number:
7.0
Last Funding Date:
2022-03-03
Founded Date:
2022-01-01
Headquarters:
Princeton, New Jersey, United States
Total Funding:
20000000.0
Last Funding Type:
Seed